Recherche
-
Childhood maltreatment and clinical severity of treatment-resistant depression in a French cohort of outpatients (FACE-DR): One-year follow-up
(Depression and Anxiety. vol. 37, n° 4, pp. 365-374, 2020)Article de revue -
Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics
(Frontiers in Psychiatry. vol. 12, 2021)Article de revueLibre accès -
Indirect effect of impulsivity on suicide risk through self-esteem and depressive symptoms in a population with treatment-resistant depression: A FACE-DR study.
(Journal of Affective Disorders. vol. 347, pp. 306-313, 2024-02-15)Article de revue -
Incidence and predictors of metabolic syndrome onset in individuals with bipolar disorders: A longitudinal study from the FACE-BD cohort.
(Acta Psychiatrica Scandinavica. vol. 149, n° 3, pp. 207-218, 2024-03-01)Article de revue -
Relationship between childhood physical abuse and clinical severity of treatment-resistant depression in a geriatric population
(PLoS ONE. vol. 4, n° 16, 2021)Article de revueLibre accès -
Violent suicide attempt history in elderly patients with bipolar disorder: The role of sex, abdominal obesity, and verbal memory: Results from the FACE-BD cohort (FondaMental Advanced center of Expertise for Bipolar Disorders)
(Journal of Affective Disorders. vol. 296, pp. 265-276, 2022-01-01)Article de revueLibre accès -
Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophrenia
(World Journal of Biological Psychiatry, 2022)Article de revueLibre accès -
Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort
(Brain, Behavior, and Immunity - Health. vol. 22, 2022-07)Article de revueLibre accès -
Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study
(Schizophrenia Bulletin Open. vol. 2, n° 1, 2021-04-27)Article de revueLibre accès -
Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)
(Frontiers in Psychiatry. vol. 9, pp. 326, 2018)Article de revueLibre accès